John M. Hill – FDA 483, Jun 22, 2026

Hillcrest Medical Research, a clinical investigator in Deland, FL, was cited for significant deficiencies during an FDA inspection. The firm failed to conduct investigations according to the investigational plan, enrolling numerous subjects who met exclusionary criteria and received investigational product. Additionally, the inspection revealed a failure to maintain adequate and accurate case histories, with multiple instances of data discrepancies and unexplained corrections.